Abeona Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Abeona Therapeutics

15/05/2024 14:35

* Abeona Therapeutics Inc  ABEO.OQ  reported a quarterly
adjusted
loss of $1.16​​ per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of -54 cents.  The mean expectation of four analysts for the
quarter was for a loss of 51 cents per share. Wall Street
expected results to range from -60 cents to -47 cents per share.
    * Reported revenue was zero​; analysts expected $166.67
thousand. 
    * Abeona Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.16​.
    * The company reported a quarterly loss of $31.58 million.
    * Abeona Therapeutics Inc shares had fallen by 42.1% this
quarter and lost 16.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Abeona
Therapeutics Inc is $17.00 
This summary was machine generated from LSEG data May 15 at
01:35 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.51          -1.16          Missed
 Dec. 31 2023      -0.47          -0.77          Missed
 Sep. 30 2023      -0.53          -0.48          Beat
 Jun. 30 2023      -0.68          -0.92          Missed